BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36567175)

  • 1. Brachytherapy impacts on sexual function: An integrative review of the literature focusing on cervical cancer.
    Chin C; Damast S
    Brachytherapy; 2023; 22(1):30-46. PubMed ID: 36567175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
    Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
    Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
    Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal dose, toxicity and sexual outcomes in patients of cervical cancer undergoing image based brachytherapy.
    Rai B; Dhanireddy B; Patel FD; Kumari R; Oinam AS; Simha V; Sharma S
    Asian Pac J Cancer Prev; 2014; 15(8):3619-23. PubMed ID: 24870767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity substudy.
    Suvaal I; Kirchheiner K; Nout RA; Sturdza AE; Van Limbergen E; Lindegaard JC; Putter H; Jürgenliemk-Schulz IM; Chargari C; Tanderup K; Pötter R; Creutzberg CL; Ter Kuile MM
    Gynecol Oncol; 2023 Mar; 170():123-132. PubMed ID: 36682090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicentre study (EMBRACE).
    Nkiwane KS; Pötter R; Tanderup K; Federico M; Lindegaard JC; Kirisits C
    Brachytherapy; 2013; 12(4):317-23. PubMed ID: 23474352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported sexual adjustment after definitive chemoradiation and MR-guided brachytherapy for cervical cancer.
    Conway JL; Gerber R; Han K; Jiang H; Xie J; Beiki-Ardakani A; Fyles A; Milosevic M; Williamson D; Croke J
    Brachytherapy; 2019; 18(2):133-140. PubMed ID: 30509730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
    Serban M; de Leeuw AAC; Tanderup K; Jürgenliemk-Schulz IM
    Brachytherapy; 2021; 20(3):565-575. PubMed ID: 33741274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of vagina equivalent dose in 2Gy fraction (EQD
    Ruanla J; Muangwong P; Kittidachanan K; Tippanya D; Thongsuk W; Kongsa A; Galalae RM; Tharavichitkul E
    Brachytherapy; 2022; 21(5):658-667. PubMed ID: 35715305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Madsen ML; Traberg A; Meisner B; Nielsen SK; Tanderup K; Spejlborg H; Fokdal LU; Nørrevang O
    Radiother Oncol; 2016 Jan; 118(1):173-5. PubMed ID: 26743833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
    Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
    Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occurrence of radiation-induced injury in vagina after radical radiotherapy of cervical cancer and its affecting factors].
    Zhang KS; Liu Z; Wang T; Wang J; Su J; Shi F; Wang RH; Yuan W; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):257-262. PubMed ID: 29747271
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors.
    Charatsi D; Vanakara P; Evaggelopoulou E; Simopoulou F; Korfias D; Daponte A; Kyrgias G; Tolia M
    Medicine (Baltimore); 2022 Jan; 101(4):e28705. PubMed ID: 35089231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer.
    Eng TY; Patel AJ; Ha CS
    Brachytherapy; 2016; 15(3):312-318. PubMed ID: 27032995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal packing volume impact on dose parameters during radiography and computed tomography based postoperative brachytherapy of cervical carcinoma.
    Tomasevic A; Plesinac-Karapandzic V; Stojanovic-Rundic S; Vuckovic S; Stevanovic J; Gavrilovic D; Nadrljanski M
    J BUON; 2017; 22(6):1509-1516. PubMed ID: 29332346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
    Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications.
    Tyree WC; Cardenes H; Randall M; Papiez L
    Int J Gynecol Cancer; 2002; 12(1):27-31. PubMed ID: 11860533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.